摘要
我国2型糖尿病(T2DM)发病率和患病率高,但知晓率和治疗达标率低。T2DM住院患者在医疗机构中呈现多学科分布,给非内分泌科带来很大的临床挑战。在DRG支付方式下,T2DM对非内分泌科进一步构成经济成本的压力。非内分泌科需要充分参考指南,遵循临床路径,规范化诊治T2DM,以期帮助患者获得最佳的临床转归,并使科室实现理想的成本控制。通过综述非内分泌科住院患者T2DM的临床路径,为非内分泌科管理T2DM提供参考。
T2DM has a high incidence and prevalence in China,but both the awareness rate and the treatment control rate are low.Inpatients with T2DM are distributed in various departments of medical institutions,causing great clinical challenges to non-endocrinology departments.DRG payment further poses economic cost pressure on non-endocrinology departments to manage T2DM.Non-endocrinology departments need to fully refer to guidelines,follow clinical pathways,and standardize the diagnosis and treatment of T2DM in order to help patients obtain the best clinical outcomes and enable these departments to achieve optimal cost control.It reviews the clinical pathways of T2DM inpatients in non-endocrinology departments,so as to provide reference for the management of T2DM in those departments.
作者
赵琨
王华
Zhao Kun;Wang Hua(Vanke School of Public Health Tsinghua University,Beijing,100084,China;不详)
出处
《中国医院管理》
北大核心
2023年第10期64-67,共4页
Chinese Hospital Management
